Aggressive periodontitis, generalized
ICD-10 K05.22 is a used to indicate a diagnosis of aggressive periodontitis, generalized.
Aggressive periodontitis, generalized, is a severe form of periodontal disease characterized by rapid attachment loss and bone destruction. This condition primarily affects adolescents and young adults, although it can occur at any age. Clinically, patients may present with symptoms such as swollen, bleeding gums, and increased mobility of teeth. The disease is often associated with specific bacterial pathogens, including Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. The disease progression can be rapid, leading to significant periodontal tissue destruction within a short time frame. Diagnosis is typically made through clinical examination, radiographic evaluation, and microbiological testing to identify pathogenic bacteria. Treatment involves a combination of mechanical debridement, antimicrobial therapy, and possibly surgical interventions to restore periodontal health. Regular follow-up is essential to monitor disease progression and ensure effective management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K05.22 covers generalized aggressive periodontitis, which includes rapid attachment loss and bone destruction affecting multiple teeth. It is distinct from localized forms of aggressive periodontitis and requires specific diagnostic criteria.
K05.22 should be used when the clinical presentation indicates generalized aggressive periodontitis, characterized by widespread periodontal tissue destruction, as opposed to localized forms or other periodontal diseases.
Documentation should include clinical examination findings, radiographic evidence of bone loss, microbiological testing results, and a detailed treatment plan. Regular follow-up notes demonstrating disease management are also essential.
